99 related articles for article (PubMed ID: 12208340)
1. Combined shock-wave and immunogene therapy of mouse melanoma and renal carcinoma tumors.
Song J; Tata D; Li L; Taylor J; Bao S; Miller DL
Ultrasound Med Biol; 2002 Jul; 28(7):957-64. PubMed ID: 12208340
[TBL] [Abstract][Full Text] [Related]
2. Lithotripter shock waves with cavitation nucleation agents produce tumor growth reduction and gene transfer in vivo.
Miller DL; Song J
Ultrasound Med Biol; 2002 Oct; 28(10):1343-8. PubMed ID: 12467861
[TBL] [Abstract][Full Text] [Related]
3. In vivo transfection of melanoma cells by lithotripter shock waves.
Bao S; Thrall BD; Gies RA; Miller DL
Cancer Res; 1998 Jan; 58(2):219-21. PubMed ID: 9443395
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of an orthotopic renal cell carcinoma model using intratumoral vector-mediated costimulation and systemic interleukin-2.
Kudo-Saito C; Wansley EK; Gruys ME; Wiltrout R; Schlom J; Hodge JW
Clin Cancer Res; 2007 Mar; 13(6):1936-46. PubMed ID: 17363550
[TBL] [Abstract][Full Text] [Related]
5. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma.
Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F
Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558
[TBL] [Abstract][Full Text] [Related]
6. Direct transfer of IL-12 gene into growing Renca tumors.
Budryk M; Wilczyńska U; Szary J; Szala S
Acta Biochim Pol; 2000; 47(2):385-91. PubMed ID: 11051203
[TBL] [Abstract][Full Text] [Related]
7. A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells.
Nishitani MA; Sakai T; Ishii K; Zhang M; Nakano Y; Nitta Y; Miyazaki J; Kanayama HO; Kagawa S; Himeno K
Cancer Gene Ther; 2002 Feb; 9(2):156-63. PubMed ID: 11857033
[TBL] [Abstract][Full Text] [Related]
8. The in vitro and in vivo effects of extracorporeal shock waves on malignant cells.
Randazzo RF; Chaussy CG; Fuchs GJ; Bhuta SM; Lovrekovich H; deKernion JB
Urol Res; 1988; 16(6):419-26. PubMed ID: 3232275
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy with TRAIL against renal cell carcinoma.
Matsubara H; Mizutani Y; Hongo F; Nakanishi H; Kimura Y; Ushijima S; Kawauchi A; Tamura T; Sakata T; Miki T
Mol Cancer Ther; 2006 Sep; 5(9):2165-71. PubMed ID: 16985049
[TBL] [Abstract][Full Text] [Related]
10. Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo.
Miller DL; Song J
Ultrasound Med Biol; 2003 Jun; 29(6):887-93. PubMed ID: 12837504
[TBL] [Abstract][Full Text] [Related]
11. Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells.
Weiss JM; Shivakumar R; Feller S; Li LH; Hanson A; Fogler WE; Fratantoni JC; Liu LN
Cancer Gene Ther; 2004 May; 11(5):346-53. PubMed ID: 15031722
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration.
Hara I; Nagai H; Miyake H; Yamanaka K; Hara S; Micallef MJ; Kurimoto M; Gohji K; Arakawa S; Ichihashi M; Kamidono S
Cancer Gene Ther; 2000 Jan; 7(1):83-90. PubMed ID: 10678360
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunity.
Saffran DC; Horton HM; Yankauckas MA; Anderson D; Barnhart KM; Abai AM; Hobart P; Manthorpe M; Norman JA; Parker SE
Cancer Gene Ther; 1998; 5(5):321-30. PubMed ID: 9824052
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonic enhancement of gene transfection in murine melanoma tumors.
Miller DL; Bao S; Gies RA; Thrall BD
Ultrasound Med Biol; 1999 Nov; 25(9):1425-30. PubMed ID: 10626630
[TBL] [Abstract][Full Text] [Related]
15. Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus (OBP-301) and IL-2 in a mouse model of renal cell carcinoma.
Huang P; Kaku H; Chen J; Kashiwakura Y; Saika T; Nasu Y; Urata Y; Fujiwara T; Watanabe M; Kumon H
Cancer Gene Ther; 2010 Jul; 17(7):484-91. PubMed ID: 20168351
[TBL] [Abstract][Full Text] [Related]
16. The dual effect of ultrasound-targeted microbubble destruction in mediating recombinant adeno-associated virus delivery in renal cell carcinoma: transfection enhancement and tumor inhibition.
Li F; Jin L; Wang H; Wei F; Bai M; Shi Q; Du L
J Gene Med; 2014; 16(1-2):28-39. PubMed ID: 24464622
[TBL] [Abstract][Full Text] [Related]
17. Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects.
Budd GT; Osgood B; Barna B; Boyett JM; Finke J; Medendorp SV; Murthy S; Novak C; Sergi J; Tubbs R
Cancer Res; 1989 Nov; 49(22):6432-6. PubMed ID: 2804986
[TBL] [Abstract][Full Text] [Related]
18. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
[TBL] [Abstract][Full Text] [Related]
19. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
20. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice.
Sun WH; Burkholder JK; Sun J; Culp J; Turner J; Lu XG; Pugh TD; Ershler WB; Yang NS
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2889-93. PubMed ID: 7708743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
